Y-mAbs Therapeutics
(NASDAQ:YMAB)
$16.50
0[0.00%]
At close: Feb 27
$16.50
0[0.00%]
After Hours: 4:00PM EDT

GET A REPORT ON YMAB SENT RIGHT TO YOUR INBOX

Q4 2023 earnings tomorrow on Thu Feb 29th after the market close
Conference call scheduled tomorrow at 8:00 AM Click to view the webcast
37.5%
Overview Rating
Unpromising asset
Technicals Analysis
66
0100
Financials Analysis
20
0100

Y-mAbs Therapeutics Stock (NASDAQ:YMAB), Quotes and News Summary

Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
Open-
Close-
Volume / Avg.0 / 360.563K
Day Range- - -
52 Wk Range2.700 - 17.270
Market Cap$719.757M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
78
Short Interest
6.2%
Days to Cover5.24
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Nov 23
1
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell
About Y-Mabs Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
YMAB
KALV

FAQ

Q

How do I buy Y-mAbs Therapeutics (YMAB) stock?

A

You can purchase shares of Y-mAbs Therapeutics (NASDAQ: YMAB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Y-mAbs Therapeutics's (YMAB) competitors?

Q

What is the target price for Y-mAbs Therapeutics (YMAB) stock?

A

The latest price target for Y-mAbs Therapeutics (NASDAQ: YMAB) was reported by HC Wainwright & Co. on Tuesday, February 20, 2024. The analyst firm set a price target for 21.00 expecting YMAB to rise to within 12 months (a possible 27.27% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Y-mAbs Therapeutics (YMAB)?

A

The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $16.5 last updated February 27, 2024 at 4:00 PM EST.

Q

Does Y-mAbs Therapeutics (YMAB) pay a dividend?

A

There are no upcoming dividends for Y-mAbs Therapeutics.

Q

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

A

Y-mAbs Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.

Q

Is Y-mAbs Therapeutics (YMAB) going to split?

A

There is no upcoming split for Y-mAbs Therapeutics.

Q

What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?

A

Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch